David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.87% |
| 2 | Consumer Discretionary | 9.92% |
| 3 | Healthcare | 7.34% |
| 4 | Financials | 7.06% |
| 5 | Communication Services | 6.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRA
3551
DELISTED
ProAssurance
PRA
| $883K | ﹤0.01% |
37,114
-30,092
| -45% | -$693K |
|
|
NMTR
3552
DELISTED
9 Meters Biopharma
NMTR
| $882K | ﹤0.01% |
33,929
-645
| -2% | -$15.2K |
|
|
DHC
3553
Diversified Healthcare Trust
DHC
$1.95B
| $881K | ﹤0.01% |
259,979
-165,924
| -39% | -$626K |
|
3554
United Natural Foods
UNFI
$2.9B
| $881K | ﹤0.01% |
+18,205
| New | +$644K |
|
3555
Alector
ALEC
$275M
| $880K | ﹤0.01% |
38,548
+471
| +1% | +$13.2K |
|
|
WW
3556
PUT
DELISTED
WW International
WW
| $880K | ﹤0.01% |
+48,200
| New | +$1.26M |
|
|
PLMJU
3557
DELISTED
Plum Acquisition Corp. III Unit
PLMJU
| $880K | ﹤0.01% |
+89,001
| New | +$883K |
|
|
ALLK
3558
DELISTED
Allakos
ALLK
| $877K | ﹤0.01% |
8,287
-79,099
| -91% | -$7.07M |
|
|
HOUS
3559
CALL
DELISTED
Anywhere Real Estate
HOUS
| $877K | ﹤0.01% |
+50,000
| New | +$881K |
|
3560
TriNet
TNET
$3.23B
| $876K | ﹤0.01% |
+9,266
| New | +$794K |
|
|
LENZ
3561
LENZ Therapeutics
LENZ
$150M
| $876K | ﹤0.01% |
+7,639
| New | +$1.13M |
|
3562
CALL
PTC
PTC
$16.5B
| $874K | ﹤0.01% |
7,300
| – | – |
|
3563
Horizon Bancorp
HBNC
$1.01B
| $872K | ﹤0.01% |
48,003
-1,434
| -3% | -$24.8K |
|
3564
Xencor
XNCR
$2.11B
| $871K | ﹤0.01% |
26,670
-18,966
| -42% | -$623K |
|
3565
CALL
Beam Therapeutics
BEAM
$3.12B
| $870K | ﹤0.01% |
10,000
| – | – |
|
3566
PUT
The RealReal
REAL
$1.33B
| $870K | ﹤0.01% |
66,000
+26,000
| +65% | +$385K |
|
3567
UMB Financial
UMBF
$10.9B
| $870K | ﹤0.01% |
9,000
+3,879
| +76% | +$354K |
|
|
TPIC
3568
DELISTED
TPI Composites
TPIC
| $869K | ﹤0.01% |
+25,758
| New | +$1.01M |
|
3569
PUT
Boston Scientific
BSX
$69.8B
| $868K | ﹤0.01% |
20,000
| – | – |
|
3570
Center Bancorp
CNOB
$1.61B
| $868K | ﹤0.01% |
28,910
-15,832
| -35% | -$438K |
|
3571
Live Nation Entertainment
LYV
$42.5B
| $868K | ﹤0.01% |
9,528
-2,525
| -21% | -$213K |
|
|
UHT
3572
Universal Health Realty Income Trust
UHT
$586M
| $864K | ﹤0.01% |
15,631
+5,694
| +57% | +$335K |
|
|
ADOC
3573
DELISTED
Edoc Acquisition Corp. Class A Ordinary Share
ADOC
| $861K | ﹤0.01% |
84,956
| – | – |
|
3574
Red Robin
RRGB
$191M
| $859K | ﹤0.01% |
+37,238
| New | +$959K |
|
3575
Simon Property Group
SPG
$70.2B
| $858K | ﹤0.01% |
+6,600
| New | +$859K |
|
Similar funds
David Shaw's Q3 2021 Portfolio in Review
As of Q3 2021, David Shaw held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
David Shaw withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, David Shaw opened a new position in Sea Limited worth $206M.
- David Shaw's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- David Shaw added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- David Shaw's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- David Shaw fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- David Shaw's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- David Shaw opened 915 new positions and closed 695 in Q3 2021.
- David Shaw's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.